Tamoxifen-treated T47D cells induced later stages of platelet activation associated with a loss of CD62P IPA and persistence of CD63 IPA reflecting hypercoagulation in both PRP and WB, compared to MCF7 cells. Here, CD63 is linked to thrombophilia.